Texas Permanent School Fund’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-55,099
Closed -$6.64M 702
2024
Q1
$6.64M Buy
55,099
+736
+1% +$90.2K 0.05% 402
2023
Q4
$6.69M Buy
54,363
+766
+1% +$95.6K 0.06% 356
2023
Q3
$6.94M Sell
53,597
-2,735
-5% -$364K 0.07% 287
2023
Q2
$6.98M Sell
56,332
-136
-0.2% -$18.3K 0.06% 300
2023
Q1
$8.26M Buy
56,468
+14,137
+33% +$2.09M 0.08% 220
2022
Q4
$6.74M Sell
42,331
-2,751
-6% -$403K 0.1% 171
2022
Q3
$6.01M Buy
45,082
+39
+0.1% +$5.93K 0.1% 186
2022
Q2
$7.03M Buy
45,043
+1,464
+3% +$225K 0.11% 146
2022
Q1
$6.78M Sell
43,579
-739
-2% -$107K 0.09% 190
2021
Q4
$5.65M Sell
44,318
-916
-2% -$120K 0.07% 299
2021
Q3
$5.89M Buy
45,234
+448
+1% +$67.7K 0.07% 274
2021
Q2
$7.96M Buy
44,786
+2,706
+6% +$469K 0.09% 185
2021
Q1
$6.92M Sell
42,080
-4,171
-9% -$686K 0.09% 217
2020
Q4
$7.63M Sell
46,251
-7,539
-14% -$1.12M 0.1% 185
2020
Q3
$7.67M Buy
+53,790
New +$6.67M 0.1% 173

Other funds holding JAZZ

Texas Permanent School Fund's JAZZ Position: Q2 2024 in Review

Texas Permanent School Fund sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2024, closing a stake of 55,099 shares — an estimated $6.64M sold.

Texas Permanent School Fund first reported a position in JAZZ in Q3 2020 and held it in 15 quarters. The position peaked at $8.26M in Q1 2023. 455 funds tracked by Wall St. Rank hold JAZZ as of Q2 2024.

  • Texas Permanent School Fund reported no remaining Jazz Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Texas Permanent School Fund sold 55,099 Jazz Pharmaceuticals shares in Q2 2024, an estimated $6.64M.
  • Texas Permanent School Fund first reported a position in Jazz Pharmaceuticals in Q3 2020 and held it in 15 quarters.
  • Texas Permanent School Fund's Jazz Pharmaceuticals position peaked at $8.26M in Q1 2023.
  • 455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2024.

Based on Texas Permanent School Fund's 13F filing for Q2 2024, filed 7 Aug 2024.